Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Catalyst Biosciences Inc (NASDAQ:CBIO)

2.23
Delayed Data
As of Feb 12
 +0.22 / +10.95%
Today’s Change
1.84
Today|||52-Week Range
21.60
-28.75%
Year-to-Date
No recent news for Catalyst Biosciences Inc.

Today’s Trading

Previous close2.01
Today’s open1.97
Day’s range1.97 - 2.23
Volume615
Average volume (3 months)36,822
Market cap$25.5M
Dividend yield25.53%
Data as of 3:57pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+30.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.40%
Revenue growth (last year)-92.22%
P/E ratioNM
Price/Sales323.06
Price/Book0.10

Competitors

 Today’s
change
Today’s
% change
ACURAcura Pharmaceutical...+0.01+0.46%
ZSANZosano Pharma Corp+0.11+5.47%
BLPHBellerophon Therapeu...-0.18-8.14%
CTRVContraVir Pharmaceut...+0.01+1.70%
Data as of 3:59pm ET, 02/12/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$275.0K
Annual profit (last year)-$32.6M
Net profit margin-11,862.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nassim Usman
Chief Financial Officer
C. Fletcher Payne
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers